A. Franklin Rice
Directeur/Membre du Conseil chez PrognosDx Health, Inc.
Profil
A.
Franklin Rice is currently a Director at PrognosDx Health, Inc. He previously worked as the Chief Executive Officer at Epalex Corp., Vice President-Biotechnology & Pharmaceuticals at Bechtel Group, Inc., Senior Director-Business Development at Genencor International, Inc., CFO, Secretary & VP-Corporate Development at VistaGen Therapeutics, Inc., and Chief Financial Officer & Secretary at Excaliber Enterprises Ltd.
He has a Master's in Business Administration from the University of Rochester, a graduate degree from the Massachusetts Institute of Technology, and an undergraduate degree from Clarkson University.
Postes actifs de A. Franklin Rice
| Sociétés | Poste | Début |
|---|---|---|
| PrognosDx Health, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de A. Franklin Rice
| Sociétés | Poste | Fin |
|---|---|---|
Epalex Corp.
 Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Directeur Général | 01/01/2019 |
VistaGen Therapeutics, Inc. /Old/
 VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | Directeur Financier/CFO | 10/06/2011 |
Excaliber Enterprises Ltd.
 Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | Directeur Financier/CFO | 10/06/2011 |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Corporate Officer/Principal | 01/01/1999 |
| VISTAGEN THERAPEUTICS, INC. | Directeur Financier/CFO | 21/12/2011 |
Formation de A. Franklin Rice
| Rochester Christian University | Masters Business Admin |
| Massachusetts Institute of Technology | Graduate Degree |
| Clarkson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Bechtel Group, Inc.
 Bechtel Group, Inc. HomebuildingConsumer Durables Bechtel Group, Inc. provides engineering and construction services. It offers technology, development, financing, ownership, procurement, safety, and environment services for roads, rail systems, airports, seaports, fossil and nuclear power plants, refineries and petrochemical facilities, mines and smelters, defense and aerospace facilities, environmental cleanup projects, telecommunications networks, pipelines and oil and gas field development services. The company is headquartered in Reston, VA. | Consumer Durables |
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | Technology Services |
| PrognosDx Health, Inc. | |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | Health Technology |
Epalex Corp.
Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Commercial Services |